blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1602725

EP1602725 - Abasic-nucleotide containing enzymatic nucleic acid [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.11.2007
Database last updated on 04.11.2024
Most recent event   Tooltip06.06.2008Change - representativepublished on 09.07.2008  [2008/28]
Applicant(s)For all designated states
SIRNA THERAPEUTICS, INC.
2950 Wilderness Place
Boulder, CO 80301 / US
[2006/07]
Former [2005/49]For all designated states
RIBOZYME PHARMACEUTICALS, INC.
2950 Wilderness Place
Boulder, CO 80301 / US
Inventor(s)01 / Usman, Nassim
2129 Night Sky Lane
Lafayette, CO 80026 / US
02 / Wincott, Francine E.
215 Upnor Rd
Baltimore, MD 21212 / US
03 / Matulic-Adamic, Jasenka
760 South 42nd Street
Boulder, CO 80303 / US
04 / Beigelmann, Leonid
5530 Colt Drive
Longmont, CO 80503 / US
 [2006/05]
Former [2005/49]01 / Usman, Nassim
2954 Kalmia , no. 37
Boulder, CO 80304 / US
02 / Wincott, Francine E.
500 Seventh Avenue 18th Floor
New York, NY 10018 / US
03 / Matulic-Adamic, Jasenka
760 South 42nd Street
Boulder, CO 80303 / US
04 / Beigelmann, Leonid
5530 Colt Drive
Longmont, CO 80503 / US
Representative(s)Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Grillparzerstraße 14
81675 München / DE
[N/P]
Former [2008/28]Viering, Jentschura & Partner
Postfach 22 14 43
80504 München / DE
Former [2005/49]Viering, Jentschura & Partner
Postfach 22 14 43
80504 München / DE
Application number, filing date05015038.219.08.1994
[2005/49]
Priority number, dateUS1993011617702.09.1993         Original published format: US 116177
US1993015248112.11.1993         Original published format: US 152481
US1994023374819.04.1994         Original published format: US 233748
[2005/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1602725
Date:07.12.2005
Language:EN
[2005/49]
Type: A3 Search report 
No.:EP1602725
Date:29.03.2006
[2006/13]
Search report(s)(Supplementary) European search report - dispatched on:EP10.02.2006
ClassificationIPC:C12N15/11, C12N9/00, C07H21/04
[2005/49]
CPC:
C07H21/00 (EP,US); C07H19/06 (EP,US); C07H19/10 (EP,US);
C07H19/16 (EP,US); C07H19/20 (EP,US); C12N15/111 (EP,US);
C12N15/113 (EP,US); C12N15/1137 (EP,US); C12N15/1138 (EP,US);
C12Y304/24017 (EP,US); C12N2310/121 (EP,US); C12N2310/315 (EP,US);
C12N2310/318 (EP,US); C12N2310/32 (EP,US); C12N2310/321 (EP,US);
C12N2310/322 (EP,US); C12N2310/33 (EP,US); C12N2310/332 (EP,US);
C12N2310/346 (EP,US); C12N2330/30 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP,US)
Designated contracting statesBE,   CH,   DE,   FR,   GB,   IT,   LI [2006/49]
Former [2005/49]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Enzymatische Nukleinsäure die Abasische Nukleotide enthaltet[2005/49]
English:Abasic-nucleotide containing enzymatic nucleic acid[2005/49]
French:Acide nucléique enzymatique contenant des nucléotides abasiques[2005/49]
Examination procedure06.07.2006Examination requested  [2006/33]
02.10.2006Despatch of a communication from the examining division (Time limit: M04)
24.01.2007Reply to a communication from the examining division
14.02.2007Despatch of a communication from the examining division (Time limit: M04)
26.06.2007Application deemed to be withdrawn, date of legal effect  [2007/50]
27.07.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2007/50]
Parent application(s)   TooltipEP02009782.0  / EP1253199
EP94925939.4  / EP0748382
Fees paidRenewal fee
11.07.2005Renewal fee patent year 03
11.07.2005Renewal fee patent year 04
11.07.2005Renewal fee patent year 05
11.07.2005Renewal fee patent year 06
11.07.2005Renewal fee patent year 07
11.07.2005Renewal fee patent year 08
11.07.2005Renewal fee patent year 09
11.07.2005Renewal fee patent year 10
11.07.2005Renewal fee patent year 11
11.07.2005Renewal fee patent year 12
29.08.2006Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
31.08.200714   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]  - MILLICAN T A ET AL, "SYNTHESIS AND BIOPHYSICAL STUDIES OF SHORT OLIGODEOXYNUCLEOTIDES WITH NOVEL MODIFICATIONS: A POSSIBLE APPROACH TO THE PROBLEM OF MIXED BASE OLIGODEOXYNUCLEOTIDE SYNTHESIS", NUCLEIC ACIDS RESEARCH, (19841011), vol. 12, no. 19, ISSN 0305-1048, pages 7435 - 7453, XP001007741 [Y] 1-4 * the whole document *
 [Y]  - USMAN N ET AL, "EXPLOITING THE CHEMICAL SYNTHESIS OF RNA", TIBS TRENDS IN BIOCHEMICAL SCIENCES, (1992), vol. 17, ISSN 0968-0004, pages 334 - 339, XP000887274 [Y] 1-4 * page 335, column L, paragraph 1; figure 1 *

DOI:   http://dx.doi.org/10.1016/0968-0004(92)90306-T
 [A]  - UHLMANN E ET AL, "ANTISENSE OLIGONUCLEOTIDES: A NEW THERAPEUTIC PRINCIPLE", CHEMICAL REVIEWS, (19900601), vol. 90, no. 4, ISSN 0009-2665, pages 543 - 584, XP000141412 [A] 1-4 * page 557, column L, line 2 - line 10; figure 33 * * page 552; figure 21 *

DOI:   http://dx.doi.org/10.1021/cr00102a001
 [A]  - ORTIGAO J F R ET AL, "ANTISENSE EFFECT OF OLIGODEOXYNUCLEOTIDES WITH INVERTED TERMINAL INTERNUCLEOTIDIC LINKAGES: A MINIMAL MODIFICATION PROTECTING AGAINST NUCLEOLYTIC DEGRADATION", ANTISENSE RESEARCH AND DEVELOPMENT, (1992), vol. 2, no. 2, ISSN 1050-5261, pages 129 - 146, XP000573884 [A] 4 * the whole document *
 [T]  - BEIGELMAN LEONID ET AL, "Synthesis of 1-deoxy-D-ribofuranose phosphoramidite and the incorporation of abasic nucleotides in stem-loop II of a hammerhead ribozyme.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (1994), vol. 4, no. 14, ISSN 0960-894X, pages 1715 - 1720, XP008007751

DOI:   http://dx.doi.org/10.1016/S0960-894X(00)80367-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.